you are

a patient


The diseases treated by RITI®

Rheumatoid arthritis is the first disease targeted by the RITI® test

Biotherapies have revolutionized the treatment of rheumatoid arthritis.

The goal of prescribing a biotherapy is to
achieve remission of the disease


Currently, there is no device available to assist doctors in choosing which biotherapy to prescribe in order to maximize the chances of remission.


Some patients do not achieve remission according to the clinical values of the DAS28 :


mYXpression has developed RITI®, the first prescription assistance test to identify biotherapies adapted to your biology.

IVDMD with CE marking

A clinical trial is currently underway at 12 French research sites
Read more

Availability is currently planned for 2025

Other diseases will be treated
by RITI® in the future

Rheumatoid arthritis

Juvenile idiopathic arthritis

Crohn's disease

Hemorrhagic rectocolitis


Do you want to learn more about the availability of RITI® for other diseases?
contact us :